Testing effectiveness (Phase 2)Study completedNCT02568449
What this trial is testing
Nintedanib in Treating Patients With Malignant Pleural Mesothelioma That Is Recurrent
Who this might be right for
Recurrent Pleural Malignant MesotheliomaStage IV Pleural Mesothelioma
Barbara Ann Karmanos Cancer Institute 20